Credits: None available.
Type: Article
Authors:
- Marom Bikson, PhD, Shames Professor of Biomedical Engineering, The City College of New York
- Dr. Nolan R. Williams, MD, Director of the Stanford Brain Stimulation Lab, Stanford Hospital and Clinics
- Eleanor Cole, PhD, Postdoctoral Scholar, Brain Stimulation Lab, Stanford University
- Abhishek Datta, PhD, Co-founder and CTO, Soterix Medical
- Dr. David Chernoff, MD, Chief Medical Officer, SetPoint Medical
- Dr. Brian H. Kopell, MD, Director; Center for Neuromodulation, Mount Sinai Health System
- Dr. Roy Hamilton, MD, Director, Penn Brain Science, Innovation, Translation, and Modulation (brainSTIM) Center, Penn Medicine
- Dr. Andres M. Lozano, MD, PhD, FRCSC, FRSC, FCAHS, RR Tasker Professor and Chairman of Neurosurgery, University of Toronto
- 2896 Dr. Elliot, Krames, Clinical Professor, Department of Anesthesia, University of California at San Francisco (UCSF)
- John Parker, PhD, Founder and Chief Science Officer, Saluda Medical
- Kevin A. Caulfield, MS, Brain Stimulation Laboratory, Department of Psychiatry, Medical University of South Carolina, Charleston
- Scott Lempka, PhD, Assistant Professor in the Departments of Biomedical Engineering and Anesthesiology, University of Michigan
- Marie-Hélène Boudrias, PhD, Associate Professor, School of Physical & Occupational Therapy, McGill University
- Yaakov Levine, PhD, Director of Research, SetPoint Medicla